Anti-cyclic citrullinated peptide antibody: An early diagnostic and prognostic biomarker of rheumatoid arthritis

Journal of Clinical and Diagnostic Research

Volumn 6, Issue 8, 2012, Pages 1393-1396

  Manivelavan, D ^a   Vijayasamundeeswari, C K ^a  

^a Vinayaka Mission's Medical College   (India)

Author keywords

Anti cyclic citrullinated peptide antibodies; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAND MALFORMATION; HUMAN; IMMUNOTURBIMETRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; PREDICTIVE VALUE; PROGNOSIS; PROTEIN FUNCTION; RADIODIAGNOSIS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

EID: 84867541668     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2012/4692.2367     Document Type: Article

References (21)

1. Niewold TB, Harrison MJ, Paget SA. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis QJM. 2007 Apr;100(4):193-201.
2. De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis. 2004 Dec;63(12):1587-93.
3. Serdaroglu, Kurbay, Deger, Cengiz, Kul. The association of Anti-CCP antibodies with disease activity in rheumatoid arthritis. Rheumatol Int 2008;28:965-70.
4. Shankar, Grover Handa. Role of Anti-Cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis. Indian J Med Res. December 2006 689-96.
5. Eric-Jan JA, Kroot EJ, De Jong BA, van Leeuwen MA, Swinkels H, Van Den Hoogen FH, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000 Aug;43(8):1831-35.
6. Arnett, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315-24.
7. Mikuls TR, Dell JR, Stoner JA, Parrish LA, Arend WP, Norris JM, et al. Association of rheumatoid arthritis treatment response and disease duration with declines inserum levels of IgM rheumatoid facto and anti-cyclic citrullinated peptide antibody. Arthritis Rheum. 2004 Dec;50(12):3776-82.
8. Pruijn, Vossenaar, Drijfhout, Van Venrooij. Zendman Anti-CCP antibody detection facilitates early diagnosis and prognosis of rheumatoid arthritis Current. Rheumatology Reviews 2005;11-71.
9. Zendman, Van Venrooij Pruijn. Use and significance of Anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology 2006;45:20-25.
10. Anill Vasishta. A Diagnosing early-onset rheumatoid arthritis: the role of Anti-CCP antibodies. Am Clin Lab. 2002 Aug-Sep; 21(7):34-36.
11. Van Venrooij WJ, Hazes JM, Visser. Hanticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med. 2002 Nov;60(10):383-88.
12. Khosla, Shankar, Duggal. Anti CCP anti bodies in rheumatoid arthritis J Indian Rheumatol Assoc 2004;12:143-46.
13. KastbomStrandberg, Lindroos, Skogh. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project) Ann Rheum Dis. 2004 September; 63(9): 1085-89.
14. Solbritt Rantapa-Dahlqvist S, De Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003 Oct;48(10):2741-49.
15. Singh, Mahajan. Anti-CCP antibodies in the diagnosis and prognosis of rheumatoid arthritis. JK Science March 2011;13(1):3-5.
16. Ravindran V, Rachapalli S. An overview o commonly used radio-graphic scoring methods in rheumatoid arthritis clinical trials. Clin Rheumatol. 2011 Jan;30(1):1-6.
17. Bas, Perneger, Seitz, Tiercy, Roux-Lombard Guerne. Diagnostic test for rheumatoid arthritis: comparision of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology 2002;41:809-14.
18. Nielen, Van Schaardenburg, Reesink, van de Stadt, Van Der Horst Bruinsma, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheumatism 2004;50;380-86.
19. Cruyssen, Cantaert, Nogueira, Clavel, de Rycke, Dendoven, Sebag, Deforce, et al. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays Arthritis Res Ther. 2006; 8(4): R122.
20. Vencovsky, Machacek, Sedova, Kafkova, Gatterova, Pesakova, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis Ann Rheum Dis 2003;62:427-30.
21. Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B. BARFOT Study Group Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (Anti-CCP), Ann Rheum Dis. 2004 Sep;63(9): 1090-95.